Biofrontera Inc.
BFRI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -22.6% | 5.1% | -31.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 72.5% | 73.6% | 64.2% | 58% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -90.6% | -55% | -45% | -8.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -95.1% | -59% | -48.9% | -11.1% |
| EPS Diluted | -0.62 | -0.57 | -0.76 | 2.97 |
| % Growth | -8.8% | 25% | -125.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |